Home > Annual Financials > SAKAR HEALTHCARE

SAKAR HEALTHCARE Financial Statement Analysis
[NSE : SAKAR]

The Revenues of SAKAR HEALTHCARE have increased by 41.76% YoY .
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has increased by 71.89 % YoY.
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Annual Financial Results
[NSE : SAKAR]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹252 Cr₹178 Cr₹153 Cr₹133 Cr₹128 Cr
Expenses ₹182 Cr₹128 Cr₹115 Cr₹100 Cr₹99 Cr
Operating Profit (Excl OI) ₹69 Cr₹50 Cr₹38 Cr₹33 Cr₹29 Cr
Other Income ₹2.29 Cr₹1.31 Cr₹3.18 Cr₹4.68 Cr₹2.17 Cr
Interest ₹8.26 Cr₹8.55 Cr₹7.62 Cr₹5.96 Cr₹2.91 Cr
Depreciation ₹24 Cr₹21 Cr₹18 Cr₹15 Cr₹9.67 Cr
Profit Before Tax ₹40 Cr₹22 Cr₹16 Cr₹17 Cr₹19 Cr
Profit After Tax ₹30 Cr₹18 Cr₹12 Cr₹13 Cr₹15 Cr
Consolidated Net Profit ₹30 Cr₹18 Cr₹12 Cr₹13 Cr₹15 Cr
Earnings Per Share (Rs)₹13.70₹7.97₹5.37₹6.70₹8.87
PAT Margin (%)12.119.867.619.5711.84
ROE(%)10.046.485.428.4813.44
ROCE(%)12.528.437.428.9512.09
Total Debt/Equity(x)0.220.310.310.690.73

Key Financials

Market Cap : ₹ 1,975.4 Cr
Revenue (TTM) : ₹ 301.8 Cr
Net Profit(TTM) : ₹ 42.9 Cr
EPS (TTM) : ₹ 19.3
P/E (TTM) : 46.1

Industry Peers & Returns1W1M1Y
SAKAR HEALTHCARE -7.5% -25.1% 169.7%
SUN PHARMACEUTICAL INDUSTRIES -1% -5.5% 5.7%
DIVIS LABORATORIES -2.6% -3.9% 38.2%
TORRENT PHARMACEUTICALS -1.7% -10.2% 30.5%
CIPLA 0.9% -3.2% -15.2%
DR REDDYS LABORATORIES -0.6% 1% -0.1%
MANKIND PHARMA -2.6% -10.6% -7.3%
LUPIN -1.6% -9.2% -1.2%
ZYDUS LIFESCIENCES 0.3% -2.9% 15.4%


SAKAR HEALTHCARE Revenues
[NSE : SAKAR]

Y-o-Y

41.76 %

5 Yr CAGR

18.37 %

Years Revenues % Change
Mar2026 ₹252 Cr
41.76
Mar2025 ₹178 Cr
15.80
Mar2024 ₹153 Cr
14.99
Mar2023 ₹133 Cr
4.00
Mar2022 ₹128 Cr -


SAKAR HEALTHCARE Operating Profit
[NSE : SAKAR]

Y-o-Y

39.42 %

5 Yr CAGR

23.97 %

Years Operating Profit % Change
Mar2026 ₹69 Cr
39.42
Mar2025 ₹50 Cr
29.47
Mar2024 ₹38 Cr
15.40
Mar2023 ₹33 Cr
13.39
Mar2022 ₹29 Cr -

Operating Margins
Y-o-Y

-1.64 %

5 Yr CAGR

4.73 %

Years Operating Margin% % Change
Mar2026 27.53%
-1.64
Mar2025 27.99%
11.83
Mar2024 25.03%
0.36
Mar2023 24.94%
9.00
Mar2022 22.88% -

SAKAR HEALTHCARE Profit After Tax
[NSE : SAKAR]

Y-o-Y

74.18 %

5 Yr CAGR

19.04 %

Years Profit After Tax % Change
Mar2026 ₹30 Cr
74.18
Mar2025 ₹18 Cr
49.96
Mar2024 ₹12 Cr
-8.53
Mar2023 ₹13 Cr
-15.95
Mar2022 ₹15 Cr -

PAT Margins
Y-o-Y

22.82 %

5 Yr CAGR

0.57 %

Years PAT Margin(%) % Change
Mar2026 12.11 %
22.82
Mar2025 9.86 %
29.57
Mar2024 7.61 %
-20.48
Mar2023 9.57 %
-19.17
Mar2022 11.84 % -

SAKAR HEALTHCARE Earnings Per Share (EPS)
[NSE : SAKAR]

Y-o-Y

71.89 %

5 Yr CAGR

11.48 %

Years EPS % Change
Mar2026 ₹14
71.89
Mar2025 ₹7.97
48.42
Mar2024 ₹5.37
-19.85
Mar2023 ₹6.70
-24.46
Mar2022 ₹8.87 -

SAKAR HEALTHCARE Return on Capital Employed (ROCE)
[NSE : SAKAR]

Y-o-Y

48.52 %

5 Yr CAGR

0.88 %

Years ROCE % Change
Mar2026 12.52%
48.52
Mar2025 8.43%
13.61
Mar2024 7.42%
-17.09
Mar2023 8.95%
-25.97
Mar2022 12.09% -

SAKAR HEALTHCARE Share Price vs Sensex

Current Share Price : ₹889.8
Current MarketCap: ₹ 1,975.4 Cr
Updated EOD on :Oct 23,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-7.5%

-25.1%

169.7%

SENSEX

-1.6%

-2.3%

-11.5%

SAKAR HEALTHCARE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SAKAR HEALTHCARE Financials


How the annual revenues of SAKAR HEALTHCARE have changed ?

The Revenues of SAKAR HEALTHCARE have increased by 41.76% YoY .

How the Earnings per Share (EPS) of SAKAR HEALTHCARE have changed?

The Earnings Per Share (EPS) of SAKAR HEALTHCARE has increased by 71.89 % YoY .